Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)4764ATolucombi 80 mg/12,5 mg tablety (tbl 84x1x80 mg/12,5 mg (blis.OPA/Al/PVC/Al))27.10.2025R
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)0540FSeptolete extra s príchuťou koly 3 mg/1 mg tvrdé pastilky (pas ord 16x3 mg/1 mg (blis. PVC/PE/PVDC/Al))20.10.2025U
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)9004EAtoritimb 10 mg/10 mg filmom obalené tablety (tbl flm 30x10 mg/10 mg (blis.oPA/Al/PVC//Al))20.10.2025U
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)9022EAtoritimb 10 mg/80 mg filmom obalené tablety (tbl flm 30x10 mg/80 mg (blis.oPA/Al/PVC//Al))20.10.2025U
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)9006EAtoritimb 10 mg/10 mg filmom obalené tablety (tbl flm 90x10 mg/10 mg (blis.oPA/Al/PVC//Al))20.10.2025U
 23.10.2025KRKA, d.d., Novo mesto (KRK-2)9024EAtoritimb 10 mg/80 mg filmom obalené tablety (tbl flm 90x10 mg/80 mg (blis.oPA/Al/PVC//Al))20.10.2025U
 23.10.2025Vipharm S.A. (VIH-PL-1)2274DErlotinib Vipharm 100 mg (tbl flm 30x100 mg (blis.OPA/Al/PVC/Al))22.10.2025O
 23.10.2025Viatris Healthcare Limited (VIM-1)43229Gopten 2 mg (cps 98x2 mg (blis.PVC/PVDC/Al))24.10.2025R
 23.10.2025CURIUM PET France (CUK-FR)4193EPylclari 1 000 MBq/ml injekčný roztok (sol inj 1x0,5-10 ml/1 000 MBq (liek.inj.skl.viacd.))21.10.2025U
 22.10.2025GlaxoSmithKline Biologicals S.A. (GAG)25982Havrix Junior 720 (0,5 ml/dávka) injekčná suspenzia v naplnenej injekčnej striekačke (sus iru 1x0,5 ml/720 E.U. (striek.inj.skl.napln.+ 1 ihla))15.9.2025R
 22.10.2025Egis Pharmaceuticals PLC (EGI)4483DAssubex 20 mg (tbl flm 28x20 mg (blis.Al/PVC/PE/PVDC))22.10.2025R
 22.10.2025Takeda Pharmaceuticals International AG Ireland Branch (TAK-IE-1)9987CTAKHZYRO 300 mg injekčný roztok (sol inj 1x2 ml/300 mg (liek.inj.skl.))22.10.2025Z
 22.10.2025B.Braun Melsungen AG (BME)80179Gentamicin B. Braun 1 mg/ml infúzny roztok (sol inf 20x80 ml/80 mg (fľ. LDPE ))22.10.2025O
 22.10.2025B.Braun Melsungen AG (BME)13897Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x250 ml (fľ.PE))22.10.2025O
 22.10.2025B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))22.10.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)